公司資料
OKYO Pharma 股價、新聞與催化劑
- 股票代碼:
- OKYO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.32 USD (-0.75%)
收盤價
最後更新: 2026年9月17日
89.2M USD
市值
股價為何變動
截至 2026年9月17日，OKYO 下跌 0.75%，收於 $1.32。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
OKYO Pharma is a biotechnology company focused on inflammation, pain, and ophthalmology-related disease biology. Its programs are aimed at serious conditions where immune modulation and localized therapy matter.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, OKYO sits in specialty biotechnology.
商業模式特徵
The company depends on clinical data, target validation, and the ability to create a differentiated inflammation and eye-care story.
生技產業定位
OKYO is a catalyst-sensitive specialty name whose stock is driven by early-stage progress.
未來催化劑
- OKYO’s catalysts are its ophthalmic-inflammatory pipeline and any update that shows the company can still build a real eye-disease story. The company remains early and data-dependent.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。